Skip to main content

Table 3 Percentage of antibiotics’ sensitivity toward different bacteria in Hospital “B” before and after the implementation of Antimicrobial Stewardship Program

From: Impact of antimicrobial stewardship on antibiogram, consumption and incidence of multi drug resistance

Bacteria

Number of cultures

Percentage of sensitive cultures for each antibiotic

P-value to compare between pre and one year after

P-value to compare between one year and two years after

One year before application of AMS program

One year after application of AMS program

Two year after application of AMS program

One year before application of AMS program

One year after application of AMS program

Two year after application of AMS program

ESBL E. coli

124

156

126

TMP/SMX ( Trimethoprim / Sulfamethoxazole)

1

22

22

26

Ciprofloxacin

0.88

23

24

24

Piperacillin-tazobactam

0.291

0.291

79

73

79

E. coli

126

177

149

Ampicillin

0.549

0.549

3

5

3

Amoxicillin—clavulanate

0.583

0.32

57

53

59

Cefuroxime

0.02

0.027

70

59

70

Ciprofloxacin

0.609

0.068

55

48

59

TMP/SMX

0.807

0.336

52

49

54

Piperacillin-tazobactam

0.012

0.185

100

93

87

Cefalexin

< 0.001

0.487

48

14

17

Levofloxacin

 

0.081

 

48

59

ESBL Klebsiella

59

32

32

Ciprofloxacin

0.21

1

20

47

50

TMP/SMX ( Trimethoprim / Sulfamethoxazole)

1

1

10

9

13

Piperacillin-tazobactam

1

1

69

66

69

Levofloxacin

1

 

47

50

Klebsiella spp

90

77

81

Amoxicillin -clavulanate

0.019

0.678

7

21

27

Amikacin

< 0.001

0.014

83

55

75

Gentamycin

< 0.001

1

70

0

1

Cefuroxime

< 0.001

0.868

70

34

37

Ceftazidime

0.001

0.009

70

39

59

Ceftriaxone

0.08

0.04

23

39

59

Ciprofloxacin

0.136

0.728

22

32

35

TMP/SMX

< 0.001

0.864

76

22

25

Ertapenem

0.035

0.017

70

53

74

Piperacillin-tazobactam

0.047

0.017

70

53

74

Imipenem

0.09

0.032

70

53

74

Meropenem

0.065

0.014

70

53

74

Tigecycline

0.099

0.032

30

47

26

Cefoxitin

 < 0.001

24

1

1

Cefalexin

 < 0.001

70

6

6

Colistin

0.081

0.014

30

47

26

Levofloxacin

0.125

 < 0.001

0

8

35

Pseudomonas aeruginosa

65

41

26

Gentamycin

0.002

1

89

63

69

Ceftazidime

0.453

0.219

85

90

73

Ciprofloxacin

 < 0.001

1

54

95

92

TMP/SMX

1

3

1

1

Piperacillin-tazobactam

 < 0.001

1

52

95

96

Imipenem

0.017

1

57

88

92

Meropenem

0.001

0.687

57

78

92

Tigecycline

 < 0.001

0.011

5

49

77

Levofloxacin

1

 

94

92

Colistin

1

1

94

93

92

Acinobacter baumanii

51

56

50

Amikacin

0.625

1

2

9

6

MRSA

7

3

19

Gentamycin

1

1

14

67

89

Ciprofloxacin

1

1

14

33

84

TMP/SMX ( Trimethoprim / Sulfamethoxazole)

1

1

57

33

79

Piperacillin-tazobactam

1

1

43

33

95

Levofloxacin

1

 

33

84

Erythromycin

1

1

14

33

26

Clindamycin

1

1

14

33

26

Strep. faecalis

 

15

13

Ampicillin

1

 

26

31

Amoxicillin-clavulanate

0.508

 

47

62

Amikacin

0.021

 

1

69

Gentamycin

0.07

 

1

54

Cefuroxime

0.021

 

1

77

Ceftazidime

0.003

 

1

92

Ceftriaxone

0.003

 

1

92

Ciprofloxacin

0.687

 

53

77

TMP/SMX

0.039

 

33

85

Ertapenem

0.008

 

20

85

Piperacillin-tazobactam

0.727

 

47

77

Imipenem

0.008

 

27

85

Meropenem

0.002

 

20

92

Tigecycline

 < 0.001

 

7

100

Levofloxacin

0.125

 

53

85

Staphylococcus aureus

55

36

15

Ampicillin

0.625

0.625

0

8

20

Amoxicillin-Clavulanate

0.006

0.375

100

69

53

Amikacin

0.006

0.004

100

69

0

Gentamycin

0.481

0.021

75

61

0

Cefuroxime

 < 0.001

 < 0.001

20

86

0

Ceftazidime

1

0.07

35

36

0

Ceftriaxone

1

0.016

25

36

0

Ciprofloxacin

0.581

0.289

44

61

47

TMP/SMX

0.21

0.18

40

64

33

Ertapenem

< 0.001

1

100

61

27

Piperacillin-Tazobactam

1

0.453

53

58

47

Tigecycline

< 0.001

 

100

13

Cefalexin

0.286

0.125

33

44

0

Levofloxacin

0.289

 

61

47

Erythromycin

0.824

0.219

51

47

1

Clindamycin

0.607

0.289

51

47

13

  1. Statistically significant values are shown in bold